Core Wealth Advisors (Florida)’s CVS Health CVS Stock Holding History

Core Wealth Advisors (Florida)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-60	Closed	-$4.79K	–	95
2024 Q1	$4.79K	Hold	60	–	–	﹤0.01%	224
2023 Q4	$4.74K	Sell	60 -174	-74%	-$12.4K	﹤0.01%	220
2023 Q3	$16.3K	Hold	234	–	–	0.01%	125
2023 Q2	$16.2K	Buy	234 +41	+21%	+$2.92K	0.01%	125
2023 Q1	$14.3K	Sell	193 -2,272	-92%	-$191K	0.01%	130
2022 Q4	$230K	Buy	2,465 +388	+19%	+$37.4K	0.1%	39
2022 Q3	$198K	Buy	2,077 +118	+6%	+$11.7K	0.12%	36
2022 Q2	$182K	Buy	1,959 +1,899	+3,165%	+$185K	0.11%	34
2022 Q1	$6K	Hold	60	–	–	﹤0.01%	162
2021 Q4	$6K	Hold	60	–	–	﹤0.01%	172
2021 Q3	$5K	Hold	60	–	–	﹤0.01%	157
2021 Q2	$5K	Hold	60	–	–	﹤0.01%	154
2021 Q1	$5K	Hold	60	–	–	﹤0.01%	139
2020 Q4	$4K	Sell	60 -1,828	-97%	-$119K	﹤0.01%	148
2020 Q3	$110K	Hold	1,888	–	–	0.1%	38
2020 Q2	$123K	Hold	1,888	–	–	0.11%	40
2020 Q1	$112K	Buy	+1,888	New	+$126K	0.09%	46

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Core Wealth Advisors (Florida)'s CVS Position: Q2 2024 in Review

Core Wealth Advisors (Florida) sold out of CVS Health (CVS) in Q2 2024, closing a stake of 60 shares — an estimated $4.79K sold.

Core Wealth Advisors (Florida) first reported a position in CVS in Q1 2020 and held it in 17 quarters. The position peaked at $230K in Q4 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Core Wealth Advisors (Florida) reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Core Wealth Advisors (Florida) sold 60 CVS Health shares in Q2 2024, an estimated $4.79K.
Core Wealth Advisors (Florida) first reported a position in CVS Health in Q1 2020 and held it in 17 quarters.
Core Wealth Advisors (Florida)'s CVS Health position peaked at $230K in Q4 2022.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Core Wealth Advisors (Florida)'s 13F filing for Q2 2024, filed 15 Aug 2024.